PACS Group, Inc. (PACS) Fair Value 2026

PACS · Services-Skilled Nursing Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

8.3 /10

32 fundamental signals · 13 models active

Value Trap Risk

(—/100)

Quick Summary — As of 2026-07-13, PACS Group, Inc. (PACS) trades at $43.29, approximately 2844% above CirclFi’s Bayesian DCF fair value of $1.47. QOC: 8.3/10. 13/13 models active.

Key Facts

Ticker
PACS
Price
$43.29
Quality Score
8.3/10
Value Trap Risk
—/100
Models Active
13/13
Last Updated
Strength: First Chicago suggests +23.8% upside with 46% confidence
Risk: Majority of models suggest overvaluation

Valuation Matrix

13 Intrinsic Value Models vs. Current Price ($43.29)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$1.47 -96.6%
Earnings Power Value
Medium Conviction
$6.20 -85.7%
CUCE Ensemble
Low Conviction
$17.27 -60.1%
First Chicago
Medium Conviction
$53.60 +23.8%

Unlock the Full Matrix

Access 9 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 13 Models →

Cancel anytime · No contracts · Instant access

What Is PACS Group, Inc. (PACS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, PACS Group, Inc.'s intrinsic value is estimated at $19.52, suggesting the stock is overvalued at its current price of $43.29. With 11 out of 13 models flagging downside (-54.9% average return), the market may be pricing in unsustainable growth. Notably, First Chicago sees the most upside at +23.8% (fair value: $53.60), while EROIC is the most conservative at -98.0% ($0.84). The spread between these extremes — +121.9% — reveals how different analytical frameworks can reach starkly different conclusions.

What Do the Models Say About PACS?

13 of 13 models are currently active for PACS. Of these, 2 models suggest upside while 11 models suggest overvaluation. The Bayesian DCF estimates PACS's intrinsic value at $1.47, implying -96.6% downside from the current price. See which stocks rank higher →

How Does PACS Rank in Services-Skilled Nursing Care Facilities?

Among 3 Services-Skilled Nursing Care Facilities stocks, PACS ranks #2 by Quality of Company score. CirclFi's QOC score of 8.3/10 evaluates 32 fundamental signals. A score of 8.3 places PACS in the top tier.

PACS Group, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is PACS a Value Trap?

The Value Trap algorithm is not active for PACS. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

13 of 13 models are active for PACS Group, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, PACS Group, Inc. is rated at 8.3/10. This strong-tier score demonstrates strong fundamentals across the majority of our quality signals.

The gap between the most bullish and bearish model spans +121.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every PACS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across PACS's 13 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy PACS Group, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Services-Skilled Nursing Care Facilities Stocks Should You Also Analyze?

2 related Services-Skilled Nursing Care Facilities stocks with 13-model coverage

Read investment analysis: ENSG · NHC

Frequently Asked Questions About PACS Group, Inc.

What is PACS Group, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, PACS Group, Inc. (PACS) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $1.47. The Quality of Company score is 8.3/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is PACS overvalued or undervalued right now?

At $43.29, 2 of 13 active models suggest PACS may be undervalued, while 11 indicate potential overvaluation. The assessment depends on which methodology best fits PACS Group, Inc.'s business model in Services-Skilled Nursing Care Facilities.

What does a Quality of Company score of 8.3 mean for PACS?

PACS Group, Inc.'s QOC of 8.3/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on PACS?

CirclFi analyzes PACS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 13 of 13 are active for this stock. Read the full methodology →

Is PACS a value trap in 2026?

CirclFi's Value Trap algorithm does not have sufficient data for PACS at this time. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 13 mathematical frameworks give you clarity on PACS.

Unlock All 13 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access